Visual outcomes of combined use of implantable collamer lens implantation and laser corneal visual correction for myopia over -18.00 diopters.

IF 2.6 3区医学 Q2 OPHTHALMOLOGY

Journal of cataract and refractive surgery Pub Date : 2024-07-01 DOI:10.1097/j.jcrs.0000000000001438

Julio Ortega-Usobiaga, Félix González-López, Yanli Peng, Rafael Bilbao-Calabuig, Jaime Beltrán-Sanz, Juan Ramón Larrubia, Fernando Llovet-Osuna

{"title":"Visual outcomes of combined use of implantable collamer lens implantation and laser corneal visual correction for myopia over -18.00 diopters.","authors":"Julio Ortega-Usobiaga, Félix González-López, Yanli Peng, Rafael Bilbao-Calabuig, Jaime Beltrán-Sanz, Juan Ramón Larrubia, Fernando Llovet-Osuna","doi":"10.1097/j.jcrs.0000000000001438","DOIUrl":null,"url":null,"abstract":"Purpose: To explore visual outcomes in patients with extreme myopia receiving an implantable collamer lens (ICL) at -18.00 diopters (D), with central port, followed by bioptics by laser vision correction (laser in situ keratomileusis [LASIK] or photorefractive keratectomy [PRK]) to address residual myopia or myopic astigmatism.Setting: Clínica Baviera (Aier Eye Hospital Group), Bilbao, Spain.Design: Retrospective analysis of cases.Methods: The study assessed uncorrected distance visual acuity, corrected distance visual acuity (CDVA), predictability, safety, efficacy, and patient satisfaction after implantation of the ICL and bioptics. The model implanted was V4c and EVO, with a correction of -18.00 D. Bioptics were performed at least 3 months after implantation, and patients were followed up for at least 3 months after LASIK or PRK.Results: The analysis included 125 eyes from 90 patients. Of these, 51.2% underwent LASIK and 48.8% PRK. Mean time from implantation to bioptics was 5.9 ± 9.4 months. Patients were followed up for a mean of 40.2 ± 37.9 months after bioptics. Median manifest refractive spherical equivalent was -2.89 D before bioptics and -0.49 D after. Median CDVA was 0.18 logMAR before bioptics and 0.17 after. The mean safety and efficacy indices were 2.22 ± 1.88 and 2.06 ± 1.85, respectively.Conclusions: Visual outcomes and safety indices after ICL implantation and subsequent LASIK or PRK in patients with extreme myopia are excellent.","PeriodicalId":15214,"journal":{"name":"Journal of cataract and refractive surgery","volume":" ","pages":"733-738"},"PeriodicalIF":2.6000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cataract and refractive surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/j.jcrs.0000000000001438","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To explore visual outcomes in patients with extreme myopia receiving an implantable collamer lens (ICL) at -18.00 diopters (D), with central port, followed by bioptics by laser vision correction (laser in situ keratomileusis [LASIK] or photorefractive keratectomy [PRK]) to address residual myopia or myopic astigmatism.

Setting: Clínica Baviera (Aier Eye Hospital Group), Bilbao, Spain.

Design: Retrospective analysis of cases.

Methods: The study assessed uncorrected distance visual acuity, corrected distance visual acuity (CDVA), predictability, safety, efficacy, and patient satisfaction after implantation of the ICL and bioptics. The model implanted was V4c and EVO, with a correction of -18.00 D. Bioptics were performed at least 3 months after implantation, and patients were followed up for at least 3 months after LASIK or PRK.

Results: The analysis included 125 eyes from 90 patients. Of these, 51.2% underwent LASIK and 48.8% PRK. Mean time from implantation to bioptics was 5.9 ± 9.4 months. Patients were followed up for a mean of 40.2 ± 37.9 months after bioptics. Median manifest refractive spherical equivalent was -2.89 D before bioptics and -0.49 D after. Median CDVA was 0.18 logMAR before bioptics and 0.17 after. The mean safety and efficacy indices were 2.22 ± 1.88 and 2.06 ± 1.85, respectively.

Conclusions: Visual outcomes and safety indices after ICL implantation and subsequent LASIK or PRK in patients with extreme myopia are excellent.

查看原文本刊更多论文

联合使用植入式准分子晶体植入术和激光角膜视觉矫正术治疗 -18.00 度以上近视的视觉效果。

目的：这一回顾性对比系列病例探讨了极度近视患者在接受-18.00屈光度（D）的可植入型有晶体眼人工晶体（ICL）和中央端口后，通过激光视力矫正（LASIK或PRK）进行生物光学矫正以解决残余近视或近视散光问题的视觉效果：研究在西班牙巴维耶拉诊所--艾尔眼科医院集团进行：设计：对病例进行回顾性分析：研究评估了植入 ICL 和生物光学器件后的未矫正远距离视力、矫正远距离视力 (CDVA)、可预测性、安全性、疗效和患者满意度。植入的型号为 V4c 和 EVO（Staar Surgical），矫正度数为 -18.00 D。生物光学检查在植入后至少 3 个月进行，患者在 LASIK 或 PRK 后至少随访 3 个月：分析包括 90 名患者的 125 只眼睛。其中，51.2% 的患者接受了 LASIK，48.8% 的患者接受了 PRK。从植入到进行生物光学检查的平均时间为 5.9 ± 9.4 个月。患者接受生物光学手术后的平均随访时间为（40.2 ± 37.9）个月。生物光学手术前的屈光球面等效中位数为-2.89 D，手术后为-0.49 D。生物光疗前的 CDVA 中位数为 0.18 logMAR，生物光疗后为 0.17 logMAR。平均安全性和有效性指数分别为 2.22 ± 1.88 和 2.06 ± 1.85：极度近视患者植入 ICL 后，再进行 LASIK 或 PRK 手术，视觉效果和安全指数都非常好。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

$Journal of cataract and refractive surgery$

Journal of cataract and refractive surgery 医学-外科

CiteScore

5.60

自引率

14.30%

发文量

259

审稿时长

8.5 weeks

期刊介绍： The Journal of Cataract & Refractive Surgery (JCRS), a preeminent peer-reviewed monthly ophthalmology publication, is the official journal of the American Society of Cataract and Refractive Surgery (ASCRS) and the European Society of Cataract and Refractive Surgeons (ESCRS). JCRS publishes high quality articles on all aspects of anterior segment surgery. In addition to original clinical studies, the journal features a consultation section, practical techniques, important cases, and reviews as well as basic science articles.